ArticleNeuro-oncology advances

HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis.

Anders W Erickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.